1. PARADIGM-2: Two parallel phase I studies of olaparib and radiotherapy or olaparib and radiotherapy plus temozolomide in patients with newly diagnosed glioblastoma, with treatment stratified by MGMT status 
Ben Fulton, Susan C. Short, Allan James, Stefan Nowicki, Catherine McBain, Sarah Jefferies, Caroline Kelly, Jon Stobo, Anna Morris, Aoife Williamson, Anthony J. Chalmers 
Clinical and Translational Radiation Oncology 
Volume 8, Pages (January 2018)
DOI: /j.ctro
Copyright © 2017 The Authors Terms and Conditions

2. Fig. 1 Study design for PARADIGM-2.
Clinical and Translational Radiation Oncology 2018 8, 12-16DOI: ( /j.ctro )
Copyright © 2017 The Authors Terms and Conditions